AGOBLISS 25 TAB is a pharmaceutical formulation containing Agomelatine 25 mg, a next-generation antidepressant known for its innovative approach to treating major depressive disorder (MDD). Unlike conventional antidepressants that primarily target monoamine neurotransmitters, Agomelatine acts as an agonist at melatonergic MT1 and MT2 receptors and as an antagonist at the 5-HT2C serotonin receptors. This dual mechanism helps in the resynchronization of circadian rhythms, which are often disrupted in patients suffering from depression. By regulating the sleep-wake cycle and promoting the release of dopamine and noradrenaline in the frontal cortex, AGOBLISS 25 effectively improves mood and restores emotional stability.
AGOBLISS 25 TAB is particularly valuable for individuals whose depression is accompanied by sleep disturbances, fatigue, and loss of motivation. It enhances sleep quality without causing daytime sedation or impairing alertness. Clinical studies have demonstrated that Agomelatine not only reduces depressive symptoms but also lowers the risk of relapse when used as a maintenance therapy. The drug begins to show effects within the first two weeks of therapy, with continued improvement over subsequent weeks. Its efficacy is comparable to traditional SSRIs and SNRIs but with a significantly reduced incidence of sexual dysfunction, weight gain, and discontinuation symptoms, making it an attractive option for long-term treatment.
AGOBLISS 25 is well-tolerated by most patients, with liver function monitoring being the primary precaution due to the possibility of hepatotoxicity in susceptible individuals. Regular liver enzyme tests are recommended, particularly during the initial months of treatment. The tablet is taken once daily, preferably at bedtime, which aligns with its role in regulating circadian rhythms and minimizing potential side effects.
BluepillExpress manufactures AGOBLISS 25 TAB under internationally recognized quality standards including WHO-GMP and ISO certification. The manufacturing process utilizes high-purity raw materials and advanced formulation technology to ensure consistent drug delivery and bioavailability. Each batch is subjected to comprehensive quality control testing to verify potency, uniformity, and stability, ensuring the product meets strict pharmaceutical standards.
AGOBLISS 25 is presented in blister packs to preserve product integrity and ensure ease of distribution. The product is available for third-party and contract manufacturing under flexible terms and private labeling options. BluepillExpress offers comprehensive support, including product dossiers, regulatory assistance, and export documentation, to help partners expand into regulated and semi-regulated international markets. With the rising prevalence of depression and related mood disorders globally, there is a growing demand for well-tolerated and effective antidepressant therapies like Agomelatine.
The inclusion of Agomelatine on various international formularies reflects its clinical significance in modern psychiatric treatment. AGOBLISS 25 TAB is ideal for psychiatrists seeking to tailor treatment to patients with complex symptoms, particularly those who do not respond well to or tolerate other antidepressants. Its unique pharmacological profile also makes it suitable for patients with seasonal affective disorder, circadian rhythm sleep disorders, and depressive episodes with marked sleep disruption.
As a third-party manufacturer, BluepillExpress provides complete end-to-end solutions for clients looking to add AGOBLISS 25 TAB to their neuropsychiatric or mental wellness portfolio. From bulk supply to custom packaging and regulatory submission support, we ensure seamless product integration for healthcare providers, wholesalers, and pharmaceutical distributors. The combination of clinical efficacy, differentiated mechanism, and strong manufacturing support makes AGOBLISS 25 TAB a valuable asset in the treatment of depressive disorders and a competitive offering for global pharmaceutical markets.
In conclusion, AGOBLISS 25 TAB stands as a modern antidepressant therapy tailored to address both mood and circadian rhythm disturbances. Manufactured by BluepillExpress with a commitment to quality, safety, and therapeutic effectiveness, it represents a forward-thinking solution in mental health treatment. Its favorable tolerability, distinctive mode of action, and support for international distribution position it as a superior choice for both patients and pharmaceutical partners seeking excellence in depression care.
Description provided by bluepill express.
FIEO Registered
Export Ready
